Email Newsletters

Marlborough

GE helping make I-495 area hot

When General Electric brings its healthcare and life sciences division to Marlborough in the spring, the 500-employee...

Marlborough business park sold for $34M

The Solomon Pond Park in Marlborough has been sold for $34 million to Burlington-based Nordblom Co., according to the Massachusetts Registry of Deeds.

Charting new courses and moving ahead

The year we're about to leave - for some, maybe forget - saw several noteworthy business-related events in Central Massachusetts, but here's our consensus selections for the top five stories of 2014. As a staff, we unanimously agreed on the top story. There was little debate over the remaining four.

What’s the outlook for 2015?

There was more optimism among Central Massachusetts business leaders heading into 2014. There's even more heading into 2015. Here are the results of this year's Economic Forecast survey, along with out predictions for the year ahead and our report card on how our predictions for 2014 turned out.
ADVERTISEMENT

Brigham Business Park in Marlborough sold

The Brigham Business Park in Marlborough has been sold for $14.5 million, according to commercial real estate firm Avison Young.

RXi: results confirm drug’s effectiveness

Marlborough-based biotechnology firm RXi Pharmaceuticals said three-month observations have confirmed the effectiveness of its first product candidate, RXI-109, in the treatment of post-surgical scars.

Briefing: Boston Scientific verdicts

Boston Scientific of Marlborough suffered a rough month in the legal system in November after two federal court juries awarded more than $45 million to eight women who claimed injuries from the medical device manufacturer's transvaginal mesh devices. What do they mean for the company?

MassEcon honors 3 Central Mass. companies

Affordable Interior Systems, Inc. of Leominster, Quest Diagnostics of Marlborough, and Pall Life Sciences of Westborough were among 18 companies from across the state honored by MassEcon this week for their contributions to the economy.
ADVERTISEMENT

Sunovion pursues seizure treatment approval for Aptiom

Sunovion Pharmaceuticals Inc. of Marlborough has submitted a supplemental new drug application to the Food and Drug Administration. The application seeks approval for the use of Aptiom for monotherapy treatment of partial-onset seizures in patients with epilepsy.

ReWalk teams with Spaulding Rehabilitation

Spaulding Rehabilitation Hospital in Boston is developing an exoskeleton training program using the systems made by ReWalk Robotics of Marlborough.
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA